Eosinopenia Predicts Prognosis in Severe Community-Acquired Pneumonia
Authors:
- Catia CillónizCCCatia Cillóniz
- Tatiana CastañedaTCTatiana Castañeda
- Antonio CampanellaACAntonio Campanella
- Riccardo GuglielmiRGRiccardo Guglielmi
- Albert GabarrúsAGAlbert Gabarrús
- Sara GraneroSGSara Granero
- Cristina Calvo-GarcíaCCCristina Calvo-García
- Maria Angeles MarcosMMMaria Angeles Marcos
- Antoni TorresATAntoni Torres
Preprint
- 14 November 2025
- preprint
- Published by Springer Nature in Research Square
Abstract
Background Eosinopenia has been reported as a marker of severity in infections, but its prognostic value in patients with severe community-acquired pneumonia (CAP) admitted to the intensive care unit (ICU) is unclear. Methods We retrospectively analyzed 496 patients with severe CAP admitted to the ICU, stratified by presence of eosinopenia at admission. Clinical characteristics, laboratory data, microbiological etiology, treatment, and outcomes were compared. Multivariable Cox regression identified independent predictors of 30-day mortality. Predictive performance of eosinophil counts, severity scores (CRB-65, CURB-65, PSI), and a modified CURB-65 incorporating eosinopenia (CURB-65Eos) were assessed. Results Eosinopenia was detected in 33% of patients. There were no differences in age and comorbidities between eosinopenic and non eosinopenic patients. Compared to non-eosinopenic patients, these patients had lower leukocyte, neutrophil, and lymphocyte counts and more frequent viral or polymicrobial infections. They more often required invasive mechanical ventilation (58% vs. 45%, p = 0.009) and developed pleural effusions (30% vs. 19%, p = 0.008). In-hospital and 30-day mortality were higher in the eosinopenia group (21% vs. 13%, p = 0.036; 20% vs. 12%, p = 0.022). Eosinopenia independently predicted 30-day mortality (HR 1.98; 95% CI 1.23–3.16; p = 0.005). Eosinophil counts alone had poor predictive accuracy (AUC 0.562), while established severity scores performed moderately. CURB-65Eos showed a numerical but nonsignificant improvement over CURB-65. Conclusions Eosinopenia is common in patients with severe CAP admitted to the ICU and is strongly associated with increased severity and mortality independent of age and comorbidities. It may serve as simple and inexpensive biomarker for the early identification of high-risk patients and could help guide more intensive therapeutic interventions.Keywords
All Related Versions
- Version 1, 2025-11-14, Research Square
- Published version: Pneumonia, 18 (1), 7.
This publication has 32 references indexed in Scilit:
- Risk Factors and Outcomes Associated With Polymicrobial Infection in Community-Acquired PneumoniaArchivos de Bronconeumología, 2025
- Eosinopenia as Predictor of Disease Severity in Patients With Community-Acquired PneumoniaChest, 2024
- [Translated article] Biological Biomarkers in Respiratory DiseasesArchivos de Bronconeumología, 2022
- PneumoniaNature Reviews Disease Primers, 2021
- The role of eosinophils in sepsis and acute respiratory distress syndrome: a scoping reviewCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2021
- Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016Intensive Care Medicine, 2017
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Eosinopenia: Is it a good marker of sepsis in comparison to procalcitonin and C-reactive protein levels for patients admitted to a critical care unit in an urban hospital?Journal of Critical Care, 2010
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996
- An Introduction to the Bootstrap1993